[1] SHEN T,LIU Y,SHANG J,et al. Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology,2019,156(8):2230-2241. e11.
|
[2] European Association for the Study of the Liver. EASL clinical practice guidelines:Drug-induced liver injury[J]. J Hepatol,2019,70(6):1222-1261.
|
[3] WANG JB,MA ZJ,NIU M,et al. Evidence chain-based causality identification in herb-induced liver injury:Exemplification of a well-known liver-restorative herb Polygonum multiflorum[J]. Front Med,2015,9(4):457-467.
|
[4] WANG JB,LI CY,ZHU Y,et al. Integrated evidence chainbased identification of Chinese herbal medicine-induced hepatotoxicity and rational usage:Exemplification by Polygonum Multiflorum(He shou wu)[J]. Chin Sci Bul,2016,61(9):971-980.(in Chinese)王伽伯,李春雨,朱云,等.基于整合证据链的中草药肝毒性客观辨识与合理用药:以何首乌为例[J].科学通报,2016,61(9):971-980.
|
[5] LI CP,RAO T,CHEN XP,et al. HLA-B*35∶01 allele is a potential biomarker for predicting polygonum multiflorum–induced liver injury in humans[J]. Hepatology,2019,70(1):346-357.
|
[6] ZHANG L,NIU M,WEI AW,et al. Risk profiling using metabolomic characteristics for susceptible individuals of druginduced liver injury caused by Polygonum multiflorum[J]. Arch Toxicol,2020,94(1):245-256.
|
[7] HE LZ,YIN P,MENG YK,et al. Immunological synergistic mechanisms of trans-/cis-stilbene glycosides in Heshouwu related idiosyncratic liver injury[J]. Sci Bull,2017,62(11):748-751.
|
[8] ZHANG L,LIU XY,TU C,et al. Components synergy between stilbenes and emodin derivatives contributes to hepatotoxicity induced by Polygonum multiflorum[J]. Xenobiotica,2019.[Epub ahead of print]
|